[Radiotherapeutic studies of head and neck cancer-highlights of the 2018 ASCO Annual Meeting].

CONCLUSION: The data presented do not justify a change of current treatment paradigms just yet. However, interesting developments can be expected in the coming years, particularly in the field of immunotherapy. PMID: 30421001 [PubMed - as supplied by publisher]
Source: HNO - Category: ENT & OMF Tags: HNO Source Type: research